SCHEMBL2118182

SCHEMBL2118182

COc1ccc(S(=O)(=O)Nc2cc(-c3ccco3)ccc2C)cn1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 3/20 0.54
KIT P10721 1/20 0.44
GHSR Q92847 4/20 0.44
PTGES2 Q9H7Z7 1/20 0.44
ALDH1A1 P00352 2/20 0.42
POLB P06746 2/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 2/20 0.41
ALOX15 P16050 2/20 0.41
CKS1B P61024 1/20 0.41
SKP2 Q13309 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
ACSS2 Q9NR19 1/20 0.41
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121409 0.87 TRIM24 (0.55) TRIM24KITGHSRALDH1A1POLB
SCHEMBL2119290 0.86 TRIM24 (0.55) TRIM24GHSRALDH1A1POLBRAB9A
SCHEMBL2116901 0.85 TRIM24 (0.49) TRIM24GHSRALDH1A1POLBRAB9A
SCHEMBL2119780 0.84 KIT (0.45) KITGHSRPTGES2ALDH1A1POLB
SCHEMBL2118328 0.81 TRIM24 (0.45) TRIM24GHSRALDH1A1POLBRAB9A
SCHEMBL2121581 0.81 TRIM24 (0.49) TRIM24GHSRALDH1A1MAPTALOX15
SCHEMBL2119450 0.81 TRIM24 (0.52) TRIM24POLBMAPTALOX15CKS1B
SCHEMBL2116620 0.80 TRIM24 (0.46) TRIM24GHSRPTGES2POLBMAPT
SCHEMBL2118988 0.79 TRIM24 (0.56) TRIM24GHSRALDH1A1POLBRAB9A
SCHEMBL2119860 0.79 TRIM24 (0.54) TRIM24KITGHSRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed
EP-2382190-A1 TOLUIDINE SULFONAMIDES AND THEIR USE AS-INHIBITORS European Molecular Biology Laboratory (EMBL) (DE) 2011-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1A, HIF1AN, EGLN3 TRIM24 2142/4885KIT 9/4885GHSR 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.